4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-21-001030
CIK 0001641640other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:14 PM ET
Size
4.8 KB
Accession
0001104659-21-001030
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-12-31$2.42/sh−30$73→ 16,694 total
Footnotes (1)
- [F1]The number of ordinary shares reported on this Form 4 reflects a 1-for-10 reverse stock split effected on December 3, 2020.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:14 PM ET
- Size
- 4.8 KB